Terms: = Head and neck cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Clinical Outcome
44 results:
1. clinical features and outcomes of advanced her2+ esophageal/GEJ cancer with brain metastasis.
Liang K; Feliciano JL; Marrone KA; Murray JC; Hann CL; Anagnostou V; Tackett SA; Shin EJ; Hales RK; Voong KR; Battafarano RJ; Yang SC; Broderick SR; Ha JS; Forde PM; Brahmer JR; Lam VK
ESMO Open; 2024 Jan; 9(1):102199. PubMed ID: 38071928
[TBL] [Abstract] [Full Text] [Related]
2. Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival.
Takano EA; Younes MM; Meehan K; Spalding L; Yan M; Allan P; Fox SB; Redfern A; Clouston D; Giles GG; Christie EL; Anderson RL; Zethoven M; Phillips KA; Gorringe K; Britt KL
BMC Cancer; 2023 May; 23(1):459. PubMed ID: 37208678
[TBL] [Abstract] [Full Text] [Related]
3. Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer.
Negrao MV; Skoulidis F; Montesion M; Schulze K; Bara I; Shen V; Xu H; Hu S; Sui D; Elamin YY; Le X; Goldberg ME; Murugesan K; Wu CJ; Zhang J; Barreto DS; Robichaux JP; Reuben A; Cascone T; Gay CM; Mitchell KG; Hong L; Rinsurongkawong W; Roth JA; Swisher SG; Lee J; Tsao A; Papadimitrakopoulou V; Gibbons DL; Glisson BS; Singal G; Miller VA; Alexander B; Frampton G; Albacker LA; Shames D; Zhang J; Heymach JV
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34376553
[TBL] [Abstract] [Full Text] [Related]
4. ErbB3, a possible prognostic factor of head and neck squamous cell carcinoma.
Kim H; Choi JY; Rah YC; Ahn JC; Kim H; Jeong WJ; Ahn SH
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Apr; 129(4):377-387. PubMed ID: 32081558
[TBL] [Abstract] [Full Text] [Related]
5. Complete Remission of Metastatic her2+ Oesophagogastric Junctional Adenocarcinoma under long-term Trastuzumab Treatment.
Gutting T; Schulte N; Belle S; Betge J; Härtel N; Wilke J; Weers J; Ebert MP; Zhan T
J Gastrointestin Liver Dis; 2019 Dec; 28(4):503-507. PubMed ID: 31826054
[TBL] [Abstract] [Full Text] [Related]
6. Elevated X-linked inhibitor of apoptosis protein (XIAP) expression uncovers detrimental prognosis in subgroups of neoadjuvant treated and T-cell rich esophageal adenocarcinoma.
Schiffmann LM; Göbel H; Löser H; Schorn F; Werthenbach JP; Fuchs HF; Plum PS; Bludau M; Zander T; Schröder W; Bruns CJ; Kashkar H; Quaas A; Gebauer F
BMC Cancer; 2019 May; 19(1):531. PubMed ID: 31151416
[TBL] [Abstract] [Full Text] [Related]
7. A mismatch of tumor grade and biologic behaviour in a rare case of Sclerosing Mucoepidermoid Carcinoma of Parotid - with review of literature.
Devi A; Narwal A; Kamboj M; Singh S
J Exp Ther Oncol; 2018 Nov; 12(4):307-315. PubMed ID: 30476387
[TBL] [Abstract] [Full Text] [Related]
8. Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.
Salem ME; Puccini A; Xiu J; Raghavan D; Lenz HJ; Korn WM; Shields AF; Philip PA; Marshall JL; Goldberg RM
Oncologist; 2018 Nov; 23(11):1319-1327. PubMed ID: 29866946
[TBL] [Abstract] [Full Text] [Related]
9. A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands.
Boon E; Bel M; van Boxtel W; van der Graaf WTA; van Es RJJ; Eerenstein SEJ; Baatenburg de Jong RJ; van den Brekel MWM; van der Velden LA; Witjes MJH; Hoeben A; Willems SM; Bloemena E; Smit LA; Oosting SF; ; Jonker MA; Flucke UE; van Herpen CML
Int J Cancer; 2018 Aug; 143(4):758-766. PubMed ID: 29492965
[TBL] [Abstract] [Full Text] [Related]
10. Adenoid cystic carcinomas of the salivary gland, lacrimal gland, and breast are morphologically and genetically similar but have distinct microRNA expression profiles.
Andreasen S; Tan Q; Agander TK; Steiner P; Bjørndal K; Høgdall E; Larsen SR; Erentaite D; Olsen CH; Ulhøi BP; von Holstein SL; Wessel I; Heegaard S; Homøe P
Mod Pathol; 2018 Aug; 31(8):1211-1225. PubMed ID: 29467480
[TBL] [Abstract] [Full Text] [Related]
11. Extreme chromosome 17 copy number instability is a prognostic factor in patients with gastroesophageal adenocarcinoma: A retrospective cohort study.
Birkness JE; Spada NG; Miller C; Luketich JD; Nason KS; Sun W; Davison JM
Genes Chromosomes Cancer; 2018 Jan; 57(1):28-34. PubMed ID: 28913947
[TBL] [Abstract] [Full Text] [Related]
12. clinical outcome and molecular characterization of brain metastases from esophageal and gastric cancer: a systematic review.
Ghidini M; Petrelli F; Hahne JC; De Giorgi A; Toppo L; Pizzo C; Ratti M; Barni S; Passalacqua R; Tomasello G
Med Oncol; 2017 Apr; 34(4):62. PubMed ID: 28315230
[TBL] [Abstract] [Full Text] [Related]
13. The AXL receptor tyrosine kinase is associated with adverse prognosis and distant metastasis in esophageal squamous cell carcinoma.
Hsieh MS; Yang PW; Wong LF; Lee JM
Oncotarget; 2016 Jun; 7(24):36956-36970. PubMed ID: 27172793
[TBL] [Abstract] [Full Text] [Related]
14. Aberrant miR-215 expression is associated with clinical outcome in breast cancer patients.
Zhou SW; Su BB; Zhou Y; Feng YQ; Guo Y; Wang YX; Qi P; Xu S
Med Oncol; 2014 Nov; 31(11):259. PubMed ID: 25270284
[TBL] [Abstract] [Full Text] [Related]
15. The degree of segmental aneuploidy measured by total copy number abnormalities predicts survival and recurrence in superficial gastroesophageal adenocarcinoma.
Davison JM; Yee M; Krill-Burger JM; Lyons-Weiler MA; Kelly LA; Sciulli CM; Nason KS; Luketich JD; Michalopoulos GK; LaFramboise WA
PLoS One; 2014; 9(1):e79079. PubMed ID: 24454681
[TBL] [Abstract] [Full Text] [Related]
16. Cooverexpression of ERBB1 and ERBB4 receptors predicts poor clinical outcome in pN+ oral squamous cell carcinoma with extranodal spread.
Silva SD; Alaoui-Jamali MA; Hier M; Soares FA; Graner E; Kowalski LP
Clin Exp Metastasis; 2014 Mar; 31(3):307-16. PubMed ID: 24338375
[TBL] [Abstract] [Full Text] [Related]
17. EGFR inhibitors augment antitumour helper T-cell responses of HER family-specific immunotherapy.
Kumai T; Matsuda Y; Oikawa K; Aoki N; Kimura S; Harabuchi Y; Celis E; Kobayashi H
Br J Cancer; 2013 Oct; 109(8):2155-66. PubMed ID: 24045666
[TBL] [Abstract] [Full Text] [Related]
18. Receptor for activated C kinase 1 (RACK1): a regulator for migration and invasion in oral squamous cell carcinoma cells.
Li J; Guo Y; Feng X; Wang Z; Wang Y; Deng P; Zhang D; Wang R; Xie L; Xu X; Zhou Y; Ji N; Hu J; Zhou M; Liao G; Geng N; Jiang L; Wang Z; Chen Q
J Cancer Res Clin Oncol; 2012 Apr; 138(4):563-71. PubMed ID: 22207523
[TBL] [Abstract] [Full Text] [Related]
19. Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction.
Wainberg ZA; Lin LS; DiCarlo B; Dao KM; Patel R; Park DJ; Wang HJ; Elashoff R; Ryba N; Hecht JR
Br J Cancer; 2011 Sep; 105(6):760-5. PubMed ID: 21811258
[TBL] [Abstract] [Full Text] [Related]
20. Detection of erbb2 copy number variations in plasma of patients with esophageal carcinoma.
Andolfo I; Petrosino G; Vecchione L; De Antonellis P; Capasso M; Montanaro D; Gemei M; Troncone G; Iolascon A; Orditura M; Ciardiello F; De Vita F; Zollo M
BMC Cancer; 2011 Apr; 11():126. PubMed ID: 21481261
[TBL] [Abstract] [Full Text] [Related]
[Next]
